Abstract
The synthesis of β-(1→3)-glucans is at present has more than a chemical challenge. The discovery of their biological properties found development for new anticancer therapies, the efficient preparation of pure and structurally well-defined β-(1→3)-glucans has generated interest in the glycochemist community. This chapter highlights recent strategies that not only yielded the target biomolecules but have also drawn attention on basic limitations. It also shows how it is possible to strengthen the activity of β-glucans by conjugation to non saccharidic derivatives.
Keywords: Glucan, synthesis, natural, biopolymer, CR3, cancer, Dectin-1, linear, donor, chemical, analog, strategy, BRM, oligo, reduction, oxygen, carbonyl, oligomer, natural, position.
About this chapter
Cite this chapter as:
Vincent Ferrières, Laurent Legentil, Balla Sylla, Karine Descroix, Caroline Nugier-Chauvin, Richard Daniellou ;Chemical Synthesis of Oligo-(1→3)-β-D-Glucans, Biology and Chemistry of Beta Glucan Volume Title: Beta-Glucan, Structure, Chemistry and Specific Application (2013) 2: 83. https://doi.org/10.2174/9781608052608113020006
DOI https://doi.org/10.2174/9781608052608113020006 |
Print ISSN 2211-0526 |
Publisher Name Bentham Science Publisher |